We further evaluated the correlation of plasma Ninj1 levels with CHA2DS2-VASc and HAS-BLED scores in patients with AF, which are recognized as risk assessment criteria for thromboembolism and bleeding, respectively. This evidence concerns the gene NINJ1 and Thromboembolism.